264 related articles for article (PubMed ID: 30822352)
1. A Modifying Autoantigen in Graves' Disease.
Latif R; Mezei M; Morshed SA; Ma R; Ehrlich R; Davies TF
Endocrinology; 2019 May; 160(5):1008-1020. PubMed ID: 30822352
[TBL] [Abstract][Full Text] [Related]
2. TSH receptor antibodies do not alter the function of gonadotropin receptors stably expressed in eukaryotic cells.
Tonacchera M; Ferrarini E; Dimida A; Agretti P; De Marco G; De Servi M; Chiovato L; Cetani F; Vitti P; Pinchera A
Eur J Endocrinol; 2004 Mar; 150(3):381-7. PubMed ID: 15012625
[TBL] [Abstract][Full Text] [Related]
3. Graves' immunoglobulins activate phospholipase A2 by recognizing specific epitopes on thyrotropin receptor.
Di Cerbo A; Di Paola R; Menzaghi C; De Filippis V; Tahara K; Corda D; Kohn LD
J Clin Endocrinol Metab; 1999 Sep; 84(9):3283-92. PubMed ID: 10487700
[TBL] [Abstract][Full Text] [Related]
4. Immunization of mice with a newly identified thyroid-stimulating hormone receptor splice variant induces Graves'-like disease.
Endo T; Kobayashi T
J Autoimmun; 2013 Jun; 43():18-25. PubMed ID: 23538203
[TBL] [Abstract][Full Text] [Related]
5. A Mouse Thyrotropin Receptor A-Subunit Transgene Expressed in Thyroiditis-Prone Mice May Provide Insight into Why Graves' Disease Only Occurs in Humans.
McLachlan SM; Aliesky HA; Rapoport B
Thyroid; 2019 Aug; 29(8):1138-1146. PubMed ID: 31184281
[No Abstract] [Full Text] [Related]
6. High affinity binding of thyrotropin (TSH) and thyroid-stimulating autoantibody for the TSH receptor extracellular domain.
Nagayama Y; Takeshita A; Luo W; Ashizawa K; Yokoyama N; Nagataki S
Thyroid; 1994; 4(2):155-9. PubMed ID: 7919997
[TBL] [Abstract][Full Text] [Related]
7. Exosomes Expressing Thyrotropin Receptor Attenuate Autoantibody-Mediated Stimulation of Cyclic Adenosine Monophosphate Production.
Edo N; Kawakami K; Fujita Y; Morita K; Uno K; Tsukamoto K; Onose H; Ishikawa T; Ito M
Thyroid; 2019 Jul; 29(7):1012-1017. PubMed ID: 31062662
[No Abstract] [Full Text] [Related]
8. Studies in mice deficient for the autoimmune regulator (Aire) and transgenic for the thyrotropin receptor reveal a role for Aire in tolerance for thyroid autoantigens.
Misharin AV; Nagayama Y; Aliesky HA; Rapoport B; McLachlan SM
Endocrinology; 2009 Jun; 150(6):2948-56. PubMed ID: 19264867
[TBL] [Abstract][Full Text] [Related]
9. A prion-like shift between two conformational forms of a recombinant thyrotropin receptor A-subunit module: purification and stabilization using chemical chaperones of the form reactive with Graves' autoantibodies.
Chazenbalk GD; McLachlan SM; Pichurin P; Yan XM; Rapoport B
J Clin Endocrinol Metab; 2001 Mar; 86(3):1287-93. PubMed ID: 11238522
[TBL] [Abstract][Full Text] [Related]
10. Evidence that TSH Receptor A-Subunit Multimers, Not Monomers, Drive Antibody Affinity Maturation in Graves' Disease.
Rapoport B; Aliesky HA; Chen CR; McLachlan SM
J Clin Endocrinol Metab; 2015 Jun; 100(6):E871-5. PubMed ID: 25856215
[TBL] [Abstract][Full Text] [Related]
11. Neutral antibodies to the TSH receptor are present in Graves' disease and regulate selective signaling cascades.
Morshed SA; Ando T; Latif R; Davies TF
Endocrinology; 2010 Nov; 151(11):5537-49. PubMed ID: 20844004
[TBL] [Abstract][Full Text] [Related]
12. The effect of thyrotropin-receptor blocking antibodies on stimulating autoantibodies from patients with Graves' disease.
Lenzner C; Morgenthaler NG
Thyroid; 2003 Dec; 13(12):1153-61. PubMed ID: 14751037
[TBL] [Abstract][Full Text] [Related]
13. Thyrotropin (TSH) receptor autoantibodies do not appear to bind to the TSH receptor produced in an in vitro transcription/translation system.
Prentice L; Sanders JF; Perez M; Kato R; Sawicka J; Oda Y; Jaskolski D; Furmaniak J; Smith BR
J Clin Endocrinol Metab; 1997 Apr; 82(4):1288-92. PubMed ID: 9100609
[TBL] [Abstract][Full Text] [Related]
14. Characterization of thyroid-stimulating blocking antibodies that appeared during transient hypothyroidism after radioactive iodine therapy.
Kung AW; Lau KS; Kohn LD
Thyroid; 2000 Oct; 10(10):909-17. PubMed ID: 11081257
[TBL] [Abstract][Full Text] [Related]
15. Insight into thyroid-stimulating autoantibody interaction with the thyrotropin receptor N-terminus based on mutagenesis and re-evaluation of ambiguity in this region of the receptor crystal structure.
Hamidi S; Chen CR; McLachlan SM; Rapoport B
Thyroid; 2011 Sep; 21(9):1013-20. PubMed ID: 21834684
[TBL] [Abstract][Full Text] [Related]
16. Thyroid stimulation does not require antibodies with identical epitopes but does involve recognition of a critical conformation at the N terminus of the thyrotropin receptor A-subunit.
Chazenbalk GD; Latrofa F; McLachlan SM; Rapoport B
J Clin Endocrinol Metab; 2004 Apr; 89(4):1788-93. PubMed ID: 15070946
[TBL] [Abstract][Full Text] [Related]
17. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.
Kamijo K; Murayama H; Uzu T; Togashi K; Olivo PD; Kahaly GJ
Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477
[TBL] [Abstract][Full Text] [Related]
18. Differences between thyrotropin receptor antibody bioactivity and inhibition of 125I-bovine thyrotropin binding.
Wallaschofski H; Kaczmarek M; Miehle K; Hentschel B; Paschke R
Thyroid; 2000 Oct; 10(10):897-907. PubMed ID: 11081256
[TBL] [Abstract][Full Text] [Related]
19. Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor.
Chazenbalk GD; Pichurin P; Chen CR; Latrofa F; Johnstone AP; McLachlan SM; Rapoport B
J Clin Invest; 2002 Jul; 110(2):209-17. PubMed ID: 12122113
[TBL] [Abstract][Full Text] [Related]
20. Exceptional hyperthyroidism and a role for both major histocompatibility class I and class II genes in a murine model of Graves' disease.
McLachlan SM; Aliesky HA; Chen CR; Williams RW; Rapoport B
PLoS One; 2011; 6(6):e21378. PubMed ID: 21738647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
